Pioneering next-generation automated micro-dissection pathology through our highly advanced Cytomask platform. Our patented science & technology deliver far superior diagnostic results, particularly for cancer patients. With pure and precise results, we unlock pathways for breakthroughs in cancer di...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2021 (4 years)
Address:
SINGAPORE, SINGAPORE, SG
The company is owned by individual shareholder(s), it has no corporate shareholder.
LOW
spending power